224
A.R. Kiasat et al. / Journal of Molecular Structure 1036 (2013) 216–225
Fig. 7. The correlation between the calculated and experimental values of some
selected bond lengths in the backbone of the entry 11.
(400 MHz, CDCl3) 2.22 (s, 3H, CH3), 3.09 (s, 3H, COCH3), 6.52
(s, 1H, CH), 7.60–769 (dd, 2H, ArH), 7.85–7.88 (m, 2H, ArH),
8.22–8.24 (dd, 3H, ArH), 8.36–8.39 (m, 1H, ArH).
Fig. 6. The optimized geometry of entry 11.
Acknowledgment
Table 8
Some of the optimized (B3LYP/6-311++Gꢀꢀ) and experimental bond lengths of the
entry 11(see Fig. 6).
We are grateful to the Research Council of Shahid Chamran Uni-
versity for financial support.
Bond
RCalc.
RExp.
Bond
RCalc.
RExp.
C26ABr48
C18AC19
C17AC18
C18AC20
C18AC21
C16AC17
C13AC22
C13AC14
C19AC15
C3AC7
N8AC13
C14AC16
N8AN9
C3AC4
C2AC6
1.904
1.555
1.548
1.544
1.539
1.526
1.526
1.512
1.497
1.483
1.480
1.457
1.418
1.407
1.403
1.403
1.891
1.541
1.527
1.534
1.528
1.510
1.514
1.449
1.488
1.476
1.480
1.449
1.419
1.386
1.380
1.404
C1AC3
1.400
1.399
1.398
1.397
1.396
1.395
1.394
1.393
1.392
1.392
1.391
1.372
1.356
1.230
1.229
1.228
1.400
1.387
1.390
1.379
1.377
1.384
1.367
1.380
1.362
1.381
1.387
1.356
1.344
1.221
1.223
1.216
Appendix A. Supplementary material
C24AC22
C15AN9
C22AC23
C23AC27
C25AC24
C26AC25
C27AC26
C1AC2
N9AC10
C6AC5
C7AN8
C14AC15
C7AO11
C16AO28
C10AO12
Supplementary data associated with this article can be found, in
References
[1] A. Basso, L. Banfi, R. Riva, G. Guanti, J. Org. Chem. 70 (2005) 575.
[2] S.T. Staben, N. Blaquiere, Angew. Chem. Int. Ed. 49 (2010) 325.
[3] T. Yue, M.X. Wang, D.X. Wang, G. Masson, J. Zhu, J. Org. Chem. 74 (2009) 8396.
[4] N. Ma, B. Jiang, G. Zhang, S.J. Tu, W. Wever, G. Li, Green Chem. 12 (2010) 1357.
[5] C. Hulme, V. Gore, Curr. Med. Chem. 10 (2003) 51.
[6] J.D. Sunderhaus, C. Dockendorff, S.F. Martin, Org. Lett. 9 (2007) 4223.
[7] F.L. Muller, T. Constantieux, J.J. Rodriguez, J. Am. Chem. Soc. 127 (2005) 17176.
[8] C. Haurena, E.L. Gall, S. Sengmany, T. Martens, M.J. Troupel, J. Org. Chem. 75
(2010) 2645.
C4AC5
[9] L.F. Tietze, M.E. Lieb, Curr. Opin. Chem. Biol. 2 (1998) 363.
[10] S. Kanakaraju, B. Prasanna, S. Basavoju, G.V.P. Chandramouli, J. Mol. Struct.
1017 (2012) 60.
[11] M.M. Heravi, B. Baghernejad, H.A. Oskooie, R. Hekmatshoar, Tetrahedron Lett.
19 (2008) 6101.
[12] Z. Khodaee, A. Yahyazadeh, N.O. Mahmoodi, M.A. Zanjanchi, V. Azimi, J. Mol.
Struct. 1029 (2012) 92.
[13] W.B. Chen, Z.J. Wu, Q.L. Pei, L.F. Cun, X.M. Zhang, W.C. Yuan, Org. Lett. 12
(2010) 3132.
1261; dH (400 MHz, CDCl3) 1.25 (6H, s, 2Me), 2.36 (2H,
s,CH2CO), 3.25-3.46 (2H, AB system, CHaHbCH2), 6.51 (1H, s,
CHN), 7.29–7.63 (4H, dd, ArCN), 7.88–8.41 (4H, m, Ph); dC
(400 MHz, CDCl3); 28.44, 28.71, 34.73, 38.06, 50.88, 64.44,
117.86, 125.82, 125.85, 127.49, 127.80, 128.16, 128.82,
128.98, 133.83, 134.74, 140.36, 151.36, 154.49, 192.12.
– 2-Acetyl-3-methyl-1-(4-Cholorophenyl)-1H-pyrazolo[1,2-
b]phthalazine-5,10-dione: (Table 3, entry 20)Yellow powder
(60%); mp 178–180 °C; Rf (23% acetone/n-hexane); 0.25; IR
[14] K. Tanaka, F. Toda, Chem. Rev. 100 (2000) 1025.
[15] A. Kumar, R.A. Maurya, Tetrahedron 63 (2007) 1946.
[16] E.C. Franklin, Chem. Rev. 16 (1935) 305.
[17] F.W. Lichtenthaler, Acc. Chem. Res. 35 (2002) 728.
[18] G. Shukla, R.K. Verma, G.K. Verma, M.S. Singh, Tetrahedron Lett. 52 (2011)
7195.
[19] L. Zhang, L.P. Guan, X.Y. Sun, C.X. Wei, K.Y. Chai, Z.S. Quan, Chem. Bio. Drug
Des. 73 (2009) 313.
(KBr)
(mmax, ) 2938, 1660, 1624, 1362, 1310; dH
cmꢂ1
(400 MHz, CDCl3) 2.28 (s, 3H, CH3), 3.09 (s, 3H, COCH3), 6.49
(s, 1H, CH), 7.35–7.45 (dd, 2H, ArH), 7.83–7.86 (m, 2H, ArH),
8.23–8.26 (dd,3H, ArH), 8.35–8.36 (m, 1H, ArH). dC (400 MHz,
CDCl3); 14.65, 30.69, 65.45, 118.83, 127.36, 128.10, 128.67,
129.16, 129.50, 129.63, 133.62, 134.34, 134.97, 135.07,
146.33, 154.24, 156.28, 193.02.
[20] Y. Nomoto, H. Obase, H. Takai, M. Teranishi, J. Nakamura, K. Kubo, Chem.
Pharm. Bull. 38 (1990) 2179.
[21] N. Watanabe, Y. Kabasawa, Y. Takase, M. Matsukura, K. Miyazaki, H. Ishihara,
K. Kodama, H.J. Adachi, J. Med. Chem. 41 (1998) 3367.
[22] S.S. El-Sakka, A.H. Soliman, A.M. Imam, Afinidad 66 (2009) 167.
[23] C.K. Ryu, R.E. Park, M.Y. Ma, J.H. Nho, Bioorg. Med. Chem. Lett. 17 (2007) 2577.
[24] J. Li, Y.F. Zhao, X.Y. Yuan, J.X. Xu, P. Gong, Molecules 11 (2006) 574.
[25] J. Sinkkonen, V. Ovcharenko, K.N. Zelenin, I.P. Bezhan, B.A. Chakchir, F. Al-
Assar, K. Pihlaja, Eur. J. Org. Chem. (2002) 2046.
– 2-Acetyl-3-methyl-1-(4-Cyanophenyl)-1H-pyrazolo[1,2-
b]phthalazine-5,10-dione: (Table 3, entry 5) Yellow powder
(70%); mp 183–185 °C; Rf (23% acetone/n-hexane); 0.25; IR
(KBr)
(
mmax
,
cmꢂ1
)
2964, 2230, 1665, 1630, 1494; dH
[26] V.P. Litvinov, Russ. Chem. Rev. 72 (2003) 69.